Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Bruker launches four new preclinical imaging systems

US-based Bruker has launched four new preclinical imaging systems at the World Molecular Imaging Congress (WMIC) 2015 in Honolulu, Hawaii.


The new Albira Si PET/SPECT/CT system will provide sub-millimeter spatial resolution across the full radial field of view (FOV), enhancing the high-resolution FOV by an order of magnitude compared against traditional PET systems.

The system is compatible with the firm’s multimodal animal beds for cross-platform MRI and optical molecular imaging.

Bruker preclinical imaging division president Dr Wulf Jung said: "At WMIC 2015, Bruker is demonstrating clear performance leadership in preclinical PET/CT and PET/MRI, and we are pleased to respond to our customers’ demand for a translational research 3 Tesla preclinical MRI with robust cryogen-free magnet technology."

Bruker’s another new BioSpec 3T Preclinical MRI system features cryogen-free magnet technology, which overcomes the reliability limitations of older cryogen-free magnets.

Featuring an 18cm magnet bore, BioSpec 3T can be upgraded to PET/MRI. The firm’s MRI CyroProbe for mice and rats, MRI sensitivity and spatial resolution can optionally be increased compared to conventional 7T MRI.

The new ParaVision 6 software features validated in vivo protocols and preclinical user interface, which unites workflows across different modalities with facile multi-modality image fusion.

The new BioSpec 3T PET/MRI aggregates Albira Si PET detector technology with MRI soft tissue contrast in one compact instrument. Built-in multimodal animal beds are said to be fully compatible with other Bruker molecular imaging systems.

High-sensitivity Xtreme II optical molecular imaging system incorporates a new CCD camera that provides new levels of performance during low-light applications such as bioluminescence and Cerenkov imaging.

With five imaging modalities, the system allows for co-registration of molecular events with access to bioluminescence, multispectral VIS-NIR fluorescence, unique direct radioisotopic imaging, and Cerenkov radiation.

Image: Bruker’s new Albira Si PET/SPECT/CT system. Photo: courtesy of Bruker Corporation.